Shawn Tomasello, MBA
DirectoratCabaletta Bio· In proxies 2023–2025
Shawn Tomasello, MBA sits on 15 public boards.
Boards1
- Cabaletta BioDirector · 1 yr on the boardIndependentCompensation, Science and Technology—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Cabaletta BioPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -80%
- 4D Molecular Therapeutics Inc.Public company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- Centrexion Therapeutics Corp.Public company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Axial Biotherapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Forte Biosciences, Inc.Public company
- Director? – PresentNo stock prices for these years
- Jasper Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Trishula Therapeutics, Inc.Public company
- Director? – PresentNo stock prices for these years
- Clementia PharmaceuticalsPublic company
- Director? – PresentNo stock prices for these years
- AlloVir, Inc.Public company
- Director? – 2025No stock prices for these years
- Gamida Cell Ltd.Public company
- Director? – 2024No stock prices for these years
- TCR2 Therapeutics Inc.Public company
- Director? – 2023No stock prices for these years
- Mesoblast, Ltd.Public company
- Director? – 2022No stock prices for these years
- Urogen Pharma LtdPublic company
- Director? – 2022No stock prices for these years
- Abeona TherapeuticsPublic company
- Director? – 2020No stock prices for these years
- Diplomat Pharmacy, Inc.Public company
- Director? – 2020No stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?